ATA Inc. Is Likely Overvalued After The Recent Asset Sale [Seeking Alpha]
ATAI Life Sciences N.V. - Common Shares (ATAI)
US:NASDAQ Investor Relations:
ir.atai.net.cn
Company Research
Source: Seeking Alpha
Summary Summary Following the sale of the profitable main operating business, ATA shareholders become owners of the remaining businesses that consistently incur losses. As this trend is likely to continue in the following years, the shares shall trade at a discount to the net cash value. Currently, the shares are pumped up to over 3 times the optimistic estimation of the net cash value of $0.57/share by day traders. The traders may not follow the company closely enough to understand that its only profitable business segment has been sold. I believe that similar to China Digital TV ( OTCPK:STVVY ), ATA will eventually trade at a discount to its net cash value of up to $0.57 per share, which represents over 74% downside from the current price. (Source: Morningstar) Sale of ATA Online ATA listed on the Nasdaq exchange in 2008. Its ATA Online segment creates professional tests for CPAs in China and various industry qualifications such as commercial banking an
Show less
Read more
Impact Snapshot
Event Time:
ATAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATAI alerts
High impacting ATAI Life Sciences N.V. - Common Shares news events
Weekly update
A roundup of the hottest topics
ATAI
News
- atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights [Yahoo! Finance]Yahoo! Finance
- atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical HighlightsGlobeNewswire
- atai Life Sciences Announces Positive Initial Results from Beckley Psytech's Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression [Yahoo! Finance]Yahoo! Finance
- atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant DepressionGlobeNewswire
- Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences?PR Newswire
ATAI
Earnings
- 3/28/24 - Beat
ATAI
Sec Filings
- 3/28/24 - Form 10-K
- 3/28/24 - Form 8-K
- 3/15/24 - Form 4
- ATAI's page on the SEC website